beta-Catenin activity negatively regulates bacteria-induced inflammation.

Area of Science:

• Microbiology
• Immunology
• Cell Biology

Background:

• Wild-type Salmonella typhimurium induces intestinal inflammation via the nuclear factor kappa B (NF-kappaB) pathway.
• WT Salmonella infection also leads to beta-catenin degradation, a key regulator of cellular proliferation.
• The regulatory mechanisms for beta-catenin and IkappaBalpha (NF-kappaB inhibitor) share similarities, including phosphorylation, ubiquitination, and proteasomal degradation.

Purpose of the Study:

• To investigate the direct role of beta-catenin in regulating the NF-kappaB pathway during Salmonella-induced inflammation in vivo.
• To elucidate the mechanism by which beta-catenin influences bacterial-induced inflammatory responses.

Main Methods:

• Utilized streptomycin-pretreated mice challenged with WT Salmonella.
• Employed siRNA to knock down glycogen synthase kinase 3beta (GSK-3beta).
• Used LiCl, a GSK-3beta inhibitor, and expressed constitutively active beta-catenin in cells.

Main Results:

• WT Salmonella infection promoted beta-catenin degradation and decreased its association with NF-kappaB.
• GSK-3beta kinase activity increased upon WT Salmonella infection, leading to IkappaBalpha stabilization when GSK-3beta was inhibited.
• Constitutively active beta-catenin stabilized IkappaBalpha and inhibited NF-kappaB activity, even with commensal bacteria or TNF-alpha treatment.

Conclusions:

• Beta-catenin degradation is linked to NF-kappaB activation during Salmonella infection.
• GSK-3beta plays a role in mediating Salmonella-induced beta-catenin degradation and subsequent inflammation.
• Beta-catenin functions as a novel negative regulator of inflammation, impacting the NF-kappaB pathway.